Engel & Novitt, LLP is an internationally-recognized boutique law firm with a global biopharmaceuticals and medical device client base spanning Europe, the United States, and the Pacific Rim. Recognized as leaders in legal/regulatory and compliance issue impacting FDA-regulated industries, Engel & Novitt develops and implements innovative and forward-thinking science-based solutions to anticipate and resolve complex scientific, science policy, legal/regulatory, legislative, life-cycle management, public policy, and business issues affecting innovative industries in the firm's core practice areas relating to drugs, biologics, medical devices, and genomics. [More]
The Engel & Novitt management and leadership team is led by its founding partners, John Engel and Anita Novitt, who lead a multi-disciplinary Team that brings many decades of experience working with cutting-edge biopharmaceuticals, device, and clinical research and drug development industries in a variety of capacities. [More]
2401 Pennsylvania Avenue, N.W., Suite 310
Washington, D.C. 20037
Telephone +1.202.207.3300 - Facsimile +1.202.207.3318 - email: < engelnovitt AT engelnovitt.com >